Driehaus Capital Management’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $45.1M | Sell |
2,477,013
-469,557
| -16% | -$8.55M | 0.36% | 90 |
|
|
2025
Q1 | $58.5M | Buy |
2,946,570
+1,575,363
| +115% | +$31.3M | 0.56% | 46 |
|
|
2024
Q4 | $23.5M | Sell |
1,371,207
-684,596
| -33% | -$11.7M | 0.19% | 157 |
|
|
2024
Q3 | $41.1M | Sell |
2,055,803
-972,864
| -32% | -$19.4M | 0.35% | 94 |
|
|
2024
Q2 | $33.9M | Buy |
3,028,667
+447,743
| +17% | +$5.01M | 0.33% | 91 |
|
|
2024
Q1 | $17M | Sell |
2,580,924
-692,668
| -21% | -$4.57M | 0.17% | 178 |
|
|
2023
Q4 | $14.8M | Sell |
3,273,592
-226,024
| -6% | -$1.02M | 0.18% | 191 |
|
|
2023
Q3 | $12.5M | Buy |
3,499,616
+69,262
| +2% | +$248K | 0.16% | 176 |
|
|
2023
Q2 | $12.7M | Buy |
+3,430,354
| New | +$12.7M | 0.16% | 190 |
|